Pathogenesis and management of lung disease in cystic fibrosis.
作者信息
Zach M S
机构信息
Department of Paediatrics, University of Graz, Universitäts-Kinderklinik, Austria.
出版信息
J R Soc Med. 1991;84 Suppl 18(Suppl 18):10-7.
Abstract
摘要
相似文献
1
Pathogenesis and management of lung disease in cystic fibrosis.
J R Soc Med. 1991;84 Suppl 18(Suppl 18):10-7.
2
Pathogenesis of cystic fibrosis airways disease.
Trans Am Clin Climatol Assoc. 2001;112:99-107.
3
Pediatric cystic fibrosis lung disease.
Minerva Pediatr. 2017 Oct;69(5):459-460. doi: 10.23736/S0026-4946.17.04949-0. Epub 2017 May 3.
4
Expanding our understanding of respiratory microbiota in cystic fibrosis.
Ann Am Thorac Soc. 2014 Sep;11(7):1084-5. doi: 10.1513/AnnalsATS.201407-303ED.
5
An overview of the pathogenesis of cystic fibrosis lung disease.
Adv Drug Deliv Rev. 2002 Dec 5;54(11):1359-71. doi: 10.1016/s0169-409x(02)00144-8.
6
Lung inflammation as a therapeutic target in cystic fibrosis.
Am J Respir Cell Mol Biol. 2004 Oct;31(4):377-81. doi: 10.1165/rcmb.2004-0124TR.
7
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
Thorax. 2017 Dec;72(12):1104-1112. doi: 10.1136/thoraxjnl-2016-209279. Epub 2017 Mar 9.
8
Bacterial infections and inflammation in the lungs of cystic fibrosis patients.
Pediatr Infect Dis J. 2001 Feb;20(2):207-13. doi: 10.1097/00006454-200102000-00018.
9
Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
Methods Mol Biol. 2011;742:3-14. doi: 10.1007/978-1-61779-120-8_1.
10
Management options for cystic fibrosis in adults.
Contemp Intern Med. 1994 Apr;6(4):31-8.
引用本文的文献
1
Annual review or continuous assessment?
J R Soc Med. 1996;89 Suppl 27(Suppl 27):3-7.
2
Cystic fibrosis: yesterday, today and tomorrow.
J R Soc Med. 1991;84 Suppl 18(Suppl 18):36-9.
本文引用的文献
1
The systematic evaluation of the chest radiograph in cystic fibrosis.
Pediatr Radiol. 1974;2(2):101-5. doi: 10.1007/BF01314939.
2
Reversible airway obstruction in cystic fibrosis.
Thorax. 1980 Oct;35(10):768-72. doi: 10.1136/thx.35.10.768.
3
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
N Engl J Med. 1981 Dec 17;305(25):1489-95. doi: 10.1056/NEJM198112173052502.
4
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients.
Infect Immun. 1980 Dec;30(3):694-9. doi: 10.1128/iai.30.3.694-699.1980.
5
Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases.
Acta Pathol Microbiol Scand C. 1980 Oct;88(5):275-80. doi: 10.1111/j.1699-0463.1980.tb00106.x.
6
Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis.
J Pediatr. 1980 Sep;97(3):351-7. doi: 10.1016/s0022-3476(80)80180-6.
7
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
Infect Immun. 1980 May;28(2):546-56. doi: 10.1128/iai.28.2.546-556.1980.
8
Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation.
Infect Immun. 1980 Feb;27(2):614-9. doi: 10.1128/iai.27.2.614-619.1980.
9
Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
J Infect Dis. 1980 Feb;141(2):238-47. doi: 10.1093/infdis/141.2.238.
10
Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.
Arch Dis Child. 1984 Dec;59(12):1131-4. doi: 10.1136/adc.59.12.1131.
Zotero 插件